Two studies in humans examined brain GCK and hypoglycemia indirectly, using fructose infusion and hypothesizing that this acted via increased brain fructose-6 phosphate to activate GCK regulatory protein (GKRP), leading in turn to inhibition of brain GCK. The gene discussed is GCKR; the disease is Hypoglycemia.